Search results
Why Bristol Myers Squibb (BMY) Outpaced the Stock Market Today
Zacks via Yahoo Finance· 5 hours agoThe latest trading session saw Bristol Myers Squibb (BMY) ending at $41.77, denoting a +1.65%...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 10 hours agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...
California State Teachers Retirement System Purchases 60,431 Shares of Bristol-Myers Squibb...
ETF DAILY NEWS· 17 hours agoCalifornia State Teachers Retirement System grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the fourth quarter, according to its most recent ...
Bristol-Myers Squibb Co. [BMY] Investment Appeal on the Rise – Knox Daily
Knox Daily· 6 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal ...
Fork Cancer fundraiser to bring delicious food, live music to Lunken Airport
The Enquirer via Yahoo News· 3 hours agoPartying for a good cause? Fork yeah! Fork Cancer, an inaugural event presented by global biopharmaceutical company Bristol Myers Squibb, is seeking to raise awareness and ...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 5 days agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 4 days agoBristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration for...
Bristol Myers Squibb Shares Cross 6% Yield Mark
Forbes· 6 days agoIn trading on Wednesday, shares of Bristol Myers Squibb were yielding above the 6% mark based on its quarterly dividend (annualized to $2.4), with the stock changing hands ...
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell...
Morningstar· 4 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma In the MCL cohort of ...
Bristol Myers Squibb checks 'yes' on another Prothena neurodegenerative therapy
FierceBiotech· 6 days agoBristol Myers Squibb is again dipping into the well of therapies being developed by Prothena, this...
